AL8326 40 mg: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

4

Conditions studied

5

US states with sites

2

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Lung cancer	1
Non-Small Cell Lung	1
Renal Cell Carcinoma (RCC)	1
Small Cell Lung Cancer	1

Recruiting trials involving AL8326 40 mg

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
NCT05363280 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations

Common questions

How many recruiting trials involve AL8326 40 mg?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.